论文部分内容阅读
目的:探究双氯芬酸钠利多卡因联合丁溴东莨菪碱治疗急性肾绞痛的临床疗效。方法:对我院2014年7月到2016年2月间接收的160例急性肾绞痛患者进行治疗,征得患者同意后,按照随机序号法将患者分为对照组和观察组,对照组采用双氯芬酸钠利多卡因治疗,观察组采用双氯芬酸钠利多卡因联合丁溴东莨菪碱治疗,观察两组效果并进行比较。结果:观察组治疗总有效率为97.5%(78/80),明显高于对照组的82.5%(66/80),结果有显著性差异(P<0.05),差异具有统计学意义。观察组不良反应发生率为7.5%(6/80)稍高于对照组5.0%(4/80),结果无显著性差异(P>0.05),差异不具有统计学意义。观察组疼痛复发率5.12%(4/78)低于对照组27.27%(18/66),结果有显著性差异(P<0.05),差异具有统计学意义。结论:双氯芬酸钠利多卡因联合丁溴东莨菪碱治疗急性肾绞痛的临床疗效良好,能够有效的提高患者的临床治疗效果,同时用药相对安全,因而值得我们在临床中借鉴使用。
Objective: To investigate the clinical efficacy of diclofenac sodium and lidocaine combined with scopolamine in the treatment of acute renal colic. Methods: A total of 160 patients with acute renal colic were enrolled in our hospital from July 2014 to February 2016. Patients were divided into control group and observation group according to random number method after consent of patients. Control group Diclofenac sodium and lidocaine treatment, the observation group using diclofenac sodium and lidocaine combined with scorpion bromide treatment, the two groups were observed and compared. Results: The total effective rate of the observation group was 97.5% (78/80), which was significantly higher than that of the control group (82.5%, 66/80). There was significant difference (P <0.05). The difference was statistically significant. The incidence of adverse reactions was 7.5% (6/80) in the observation group slightly higher than that in the control group (5.0%, 4/80). There was no significant difference (P> 0.05) between the two groups. The difference was not statistically significant. The recurrence rate was 5.12% (4/78) in the observation group and 27.27% (18/66) in the control group, with significant difference (P <0.05). The difference was statistically significant. Conclusion: Diclofenac sodium lidocaine combined with scopolamine bromide in the treatment of acute renal colic has a good clinical curative effect, which can effectively improve the clinical effect of the patients. At the same time, the medication is relatively safe, so it is worth our reference for clinical use.